×
Invest
Why invest in Medtech with us?
Join our next pitch
Fundraise
Fundraise With Us
Apply For Funding
Portfolio
Investment Portfolio
Investment History
Exits
About
FAQ’s
Members
Investor deal flow access (coming soon)
Investor documents access
Investor portfolio access
News
Contact
MENU
EXITS
Oncomark, acquired in March 2021 by Cepheid, part of Danaher
AventaMed, acquired in February 2023 by Karl Stortz
Embo Medical, acquired in December 2015 by Clearstream, part of CR Bard
Copyright Medtech Syndicate ©2025 all rights reserved